Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Health Care Cost
85%
Malaria
74%
Glucose 6 Phosphate Dehydrogenase
48%
Therapeutic Procedure
47%
Plasmodium Vivax Malaria
41%
Health
39%
Patient
38%
Child
30%
Diseases
27%
Primaquine
27%
Infection
26%
Diagnosis
24%
Hepatitis B
24%
Systematic Review
24%
Observational Study
24%
Analysis
22%
Glucose-6-Phosphate Dehydrogenase Deficiency
20%
Hepatitis B Virus
16%
Woman
14%
Rapid Diagnostic Test
14%
Low and Middle Income Countries
13%
Human Immunodeficiency Virus
12%
Hospital
12%
Trace Element
12%
Glucose 6 Phosphate
12%
Cluster Randomized Trial
12%
Volunteer
12%
Supplementation
12%
Cervical Cancer Screening
12%
Pregnancy
12%
Anemia
12%
Marginalised Population
12%
Domestic Violence
12%
Primary Health Care
12%
Drug Administration
12%
Herpes Genitalis
12%
Toddlers
12%
Scabies
12%
Quality of Life
12%
Drug
10%
8-Aminoquinoline
10%
Tafenoquine
9%
Disability Adjusted Life Years
9%
Sensitivity Analysis
9%
Comprehension
9%
Iron Supplement
8%
Malaria Control
7%
Female
7%
Acetic Acid
6%
Nursing and Health Professions
Cost Effectiveness Analysis
36%
Procedures
24%
Household
20%
Hospital
18%
Woman
14%
Primary Medical Care
12%
Phosphate Deficiency
12%
Glucose 6 Phosphate Dehydrogenase Deficiency
12%
Genital Herpes
12%
Quality of Life
12%
Antimalarial Agent
9%
Health Care Personnel
9%
Health Service
7%
Economic Evaluation
6%
Patient
6%
Health Care Facility
6%
Quality Control
6%
Herpes Simplex
5%
Data Base
5%